Allied Market Research published a report, titled, “Cell Culture Media Market by Type (Natural Media, Artificial Media), by Application (Biopharmaceutical Production, Regenerative Medicine and Tissue Engineering, Diagnostics, Drug Screening and Development, Others), by End User (Biotechnology and Pharmaceutical Industry, Research and Academic Institute, Hospitals and Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “cell culture media market” was valued at $5.2 billion in 2023, and is estimated to reach $17.6 billion by 2035, growing at a CAGR of 10.7% from 2024 to 2035.
The cell culture media market is driven by the rising demand for biopharmaceuticals, increasing focus on personalized medicine, and advancements in cell-based research, including regenerative medicine. Opportunities lie in the growing adoption of 3D cell culture technologies and the rising need for serum-free and chemically defined media to enhance reproducibility and scalability in bioproduction.
Request Sample of the Report on – https://www.alliedmarketresearch.com/request-sample/A47229
Biopharmaceutical companies rely on cell culture media to ensure optimal cell growth, high-yield production, and consistent product quality. Moreover, the rise in global healthcare spending, coupled with advancements in bioprocessing technologies, has further accelerated the adoption of cell culture media in the large-scale production of life-saving biologics and personalized therapies.
The different types of media serve specific research needs, including basal media for general cell culture, serum-free media (SFM) for reducing variability, and specialized formulations for tasks like stem cell research or cancer studies. As it is widely used in biotechnology, pharmacology, and vaccine development, cell culture media plays a crucial role in advancing scientific and medical research. The growing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies, is a major growth driver for the cell culture media market size.
The cell culture media market trends such as advancements in biopharmaceutical production, increasing adoption of 3D cell culture technologies, and growing research in cell-based therapies and regenerative medicine drive the growth of the market. Moreover, the increasing global prevalence of chronic diseases such as cancer and autoimmune disorders has accelerated investments in biopharmaceutical research and production. In addition, government initiatives supporting biotechnology advancements and healthcare infrastructure expansion have fueled market growth.
Segmental Overview
By type:
The artificial media segment held the largest market share in 2023, accounting for four-fifths of the cell culture media market owing to its ability to provide a consistent, controlled environment for cell growth and proliferation. Artificial media are highly customizable, allowing researchers to adjust nutrient composition, pH levels, and growth factors to meet specific experimental or production needs. Their scalability and reproducibility make them ideal for large-scale biopharmaceutical manufacturing, including vaccine production and monoclonal antibody development. Additionally, advancements in synthetic media formulations have improved cell viability, productivity, and shelf life, further strengthening their market dominance. Their widespread use in research, drug development, and clinical applications continues to drive growth in this segment.
By application:
The biopharmaceutical production segment held the largest market share in 2023, accounting for around two-fifths of the cell culture media market owing to the essential role cell culture media play in the production of biopharmaceuticals such as monoclonal antibodies, vaccines, and gene therapies. Biopharmaceutical companies rely on cell culture systems to produce biologics at large scales, making the need for high-quality, optimized cell culture media crucial for ensuring efficient and cost-effective production. Cell culture media provide the nutrients and growth factors required for the cells to grow, proliferate, and produce the therapeutic proteins needed.
By end user:
The biotechnology and pharmaceutical industry segment held the largest market share in 2023, accounting for around half of the cell culture media market owing to the critical role cell culture media play in the production of biopharmaceuticals and the development of innovative therapies. Biotech and pharmaceutical companies rely heavily on cell culture systems for the development and manufacturing of biologics, such as monoclonal antibodies, vaccines, and gene therapies. These companies use specialized cell culture media to support the growth and productivity of cells used in drug production, ensuring high-quality yields and efficient processes.
By Region:
The North America segment held the largest market share in 2023, accounting for two-fifths of the cell culture media market due to the region’s advanced healthcare infrastructure, strong research capabilities, and significant investment in medical and biotechnology research which contribute to the high demand for cell culture media. Additionally, North America benefits from a robust regulatory environment that supports the development and commercialization of new biologics, further driving market growth. The presence of leading research institutions, pharmaceutical companies, and biotechnology firms in the United States and Canada, along with increasing government and private funding for healthcare innovation, has reinforced North America’s dominant position in the cell culture media market.
Recent Developments
- In August 2022, Thermo Fisher Scientific Inc. announced the expansion of their dry powder media manufacturing facility in Grand Island, New York. The company expanded its production capacity to meet the increasing demand for culture media used for the manufacturing of new vaccines and biologics.
- In July 2023, Merck KGaA announced the expansion of its facility in Lenexa, Kanas, USA in order to expand cell culture media production. This is expected to meet the company’s commitment with the dynamic needs of customers worldwide and delivering on growth plans.
Leading Market Players
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- STEMCELL Technologies Inc.
- Sartorius Stedim Biotech S.A.
- PromoCell GmbH
- Lonza Group AG
- Corning Incorporated
- Fujifilm Holdings Corporation
- Takara Bio USA, Inc.
Read More:
What is a Handheld X-Ray Imaging Device?
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
